Identification of A0 minimum ablative margins for colorectal liver metastases: multicentre, retrospective study using deformable CT registration and artificial intelligence-based autosegmentation.

Journal: The British journal of surgery
PMID:

Abstract

BACKGROUND: Several ablation confirmation software methods for minimum ablative margin assessment have recently been developed to improve local outcomes for patients undergoing thermal ablation of colorectal liver metastases. Previous assessments were limited to single institutions mostly at the place of development. The aim of this study was to validate the previously identified 5 mm minimum ablative margin (A0) using autosegmentation and biomechanical deformable image registration in a multi-institutional setting.

Authors

  • Iwan Paolucci
    Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ipaolucci@mdanderson.org.
  • Jessica Albuquerque Marques Silva
    Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yuan-Mao Lin
    Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gregor Laimer
    Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
  • Valentina Cignini
    Department of Surgical Sciences, University of Turin, Turin, Italy.
  • Francesca Menchini
    Department of Surgical Sciences, University of Turin, Turin, Italy.
  • Marcio Meira
    Department of Radiology, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil.
  • Alexander Shieh
    Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Caleb O'Connor
    Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kyle A Jones
    Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Carlo Gazzera
    Department of Diagnostic Imaging and Interventional Radiology, Città della Salute e della Scienza, Turin, Italy.
  • Paolo Fonio
    Department of Diagnostic Imaging and Interventional Radiology, Città della Salute e della Scienza, Turin, Italy.
  • Kristy K Brock
    Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Marco Calandri
    Oncology Department, University of Turin, AOU San Luigi Gonzaga, 10043 Orbassano, Italy.
  • Marcos Menezes
    Department of Radiology, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil.
  • Reto Bale
    Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria. reto.bale@i-med.ac.at.
  • Bruno C Odisio
    Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.